HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreU.S. Reps. Raul Ruiz, MD (D-CA), Gabe Evans (R-CO), and Debbie Wasserman Shultz (D-FL), introduced ACR®-supported legislation July 15, that would establish a grant program to fund the purchase of new mobile cancer screening units, bringing essential screenings directly to those who need them most. The Mobile Cancer Screening Act (H.R. 4417) particularly helps individuals living in rural or underserved areas who often find it difficult to access cancer screenings.
The bill would enable healthcare organizations to purchase new mobile cancer screening units under a program within the Health Resources and Services Administration (HRSA), with an emphasis on lung cancer. The grants would cover most of the costs for a new unit, including the vehicle, low-dose CT and software.
In a statement released by Rep. Ruiz, ACR CEO, Dana H. Smetherman, MD, MPH, MBA, FACR, said, “Lifesaving imaging technologies cannot save lives if they are not available in our communities. This bill is an important step toward ensuring and expanding access to modern screening exams, helping us catch more cancers early, and giving more people the chance to live longer, healthier lives.”
If you have questions, contact Ashley Walton, ACR Government Affairs Director.
HOPPS Proposed Rule Would Grow Site-Neutral Imaging Payments
ACR® has prepared a preliminary summary of the 2027 HOPPS proposed rule released by CMS July 2. CMS proposes to increase outpatient hospital payment rates by 2.4%.
Read moreACR Weighs in on NRC Standard General License Proposal
ACR supports easing NRC licensing burdens but urges limits on new SGL use, ensuring existing training standards and clarity within broader regulatory reforms.
Read moreDr. Pisano Highlights ACR AI Leadership and Builds International Connections
Etta Pisano urged global collaboration on safe, effective medical AI and highlighted ACR programs advancing AI standards and clinical trial innovation.
Read more